Company profile
Hero Technologies Inc.
OTC: HENC · Healthcare · Drug Manufacturers - Specialty & Generic
#1161 of 1,418 Healthcare companies by revenuebottom-decile growth
EA Score
——FH —DQ 15GM —SS 31
v0.1 · 25/100 weight · pillars only
↑ listing tenure, Piotroski F · ↓ workforce scale, revenue growth (YoY)
Methodology →Revenue TTM
$0
Rev growth YoY (TTM)
-100.0%
Net income (FY)
-$541.6k
Employees
1
as of 2026-08-28
Market cap
$55.3k
as of 2026-08-28
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$0$02022
Net income-$541.6k-$541.6k2022
Operating income-$31.2M-$31.2M2022
Total assets$645.2k$645.2k2022
Liabilities$835.5k$835.5k2022
Equity-$190.3k-$190.3k2022
Revenue trend
FY2021 – FY2022 · USD
FY21
FY21
FY22
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Hero Technologies Inc.’s revenue?
Hero Technologies Inc. booked $0 in FY2022 revenue, contracting 100% year over year — among the slowest-growing Healthcare companies we track, at a -Infinity% net margin.
Peers · Healthcare
Biome Grow Inc.——Street Capital Inc.18DMera Pharmaceuticals, Inc.——SOAFEE, Inc.——Nunzia Pharmaceutical Company——Petlife Pharmaceuticals, Inc.——Neighbors
Kent →Key facts
CEODestiny Aigbe
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersDover, DE
ExchangeOTC: HENC
Employees1
IPO date2007-02-14
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.